Category Archives: Muscular Dystrophy Treatment

Last week was an unusually busy week for clinical trial news, with numerous companies presenting results at conferences. Heres a look at the top stories Continue reading →

IN AN ABRUPT about-face, the Trump administration is reversing course on the recent declaration that it was ending a policy that allowsseriously ill immigrants to remain in the country legally to receive medical treatment. The protected status, called medical deferred action, was eliminated on August 7 when the US Customs and Immigration Services agency began sending denial letters to patients and families requiring them to leave the country within 33 days or face deportation Continue reading →

Continuing an almost decade-long tradition of fundraising, Paris Fire Department is selling shirts to raise funds for cancer treatment and this year, its staying local, Deputy Fire Chief Randy Crawford said. Last years check went to the American Cancer Society Paris branch, which then donated the funds to a local recipient to assist with medical bills and treatment, Paris Fire Capt. James Dority said. Continue reading →

SAN FRANCISCO and TOKYO, Sept. 20, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. Continue reading →

It was 2012, and research into brain-machine interfaces was stuck. The technology, which links brain waves to devicessuch as computers or robotic arms, promised to open the world back up for paralyzed peoplebut it was held up by a fundamental issue Continue reading →

Thursday, September 19, 2019 4:02 p.m. CDT by Michael Leischner GREEN BAY, WI (WSAU) -- Officials with the Muscular Dystrophy Association have released the final fundraising totals for the 2019 Tomahawk Fall Ride, calling this year's event a success Continue reading →

Global interest in cell and gene therapies is on the rise, and continued growth is expected for the coming years. To discuss the challenges and solutions associated with manufacturing viral vectors at the scales and quality required for these therapeutics to be approved by the regulatory authorities, representatives from Pall and Molmed jointly hosted a seminar in Tokyo earlier this year. Pall representatives focused on the equipment they have available, while their colleagues at Molmed gave perspectives as contract manufacturers using the equipment for production. Continue reading →

CEDARHURST, N.Y., Sept. 19, 2019 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. Continue reading →

Text size Countless small- and mid-cap public biotech firms compete for attention and investment dollars. Analysts at Citi Research anointed two of them as Top 5 Buys: Sarepta Therapeutics , which is coming off a difficult year, and Amarin , which is trading more than 500% higher than it did twelve months ago. Continue reading →

ASHIKA Rubikisson had a normal pregnancy with no complications. Her son, Shannon, seemed to be developing normally in his toddler years, but at around 5, his family noticed he had trouble walking Continue reading →